As doctors and nurses around the world work tirelessly to care for those affected by COVID-19, there are many other healthcare professionals actively searching for a cure – some of whom are in Nashville’s own backyard at Vanderbilt University Medical Center.
Director of Vanderbilt Vaccine Center Dr. James Crowe and his team are currently working on an antibody therapy that would help stop the spread of coronavirus until a vaccine is ready for public use. According to John Hopkins’ University’s Center For Systems Science and Engineering, there are 1.5 million cases of coronavirus worldwide, causing nearly 95,000 deaths. The Centers for Disease Control and Prevention (CDC) reports that the U.S. has more than 427,000 cases with nearly 15,000 deaths. A common misconception when the outbreak occurred is that it’s similar to the common flu. However, Crowe points out there are crucial differences. “One of the things that might be different about the coronavirus and flu is that it appears people are quite infectious in days before they have symptoms, and that’s less true about flu usually,” he tells Sounds Like Nashville over the phone. “When you’re not showing symptoms, you’re not particularly infectious with flu, and when you start having sneezing or coughing, by then you’re infectious.”
Read more here.